[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks

Q1 Earnings Outperformers: United Therapeutics (NASDAQ:UTHR) And The Rest Of The Therapeutics Stocks

UTHR : 542.66 (-0.13%)
These 3 Stocks Lowered Their Share Counts Drastically in Q1

Pinterest, Southwest Airlines, and United Therapeutics each executed significant share repurchases in Q1 2026, reducing their outstanding share counts by 16%, 5%, and 3.2%, respectively.

PINS : 20.82 (+6.88%)
LUV : 51.91 (-0.35%)
UTHR : 542.66 (-0.13%)
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

VSTS : 14.42 (+4.95%)
CNX : 33.73 (+0.36%)
UTHR : 542.66 (-0.13%)
2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down

2 Mid-Cap Stocks on Our Buy List and 1 We Turn Down

NVMI : 488.58 (-8.55%)
SYF : 78.66 (+0.18%)
UTHR : 542.66 (-0.13%)
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on...

UTHR : 542.66 (-0.13%)
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026

The pivotal TETON-1 phase 3 study of nebulized Tyvaso® (treprostinil) Inhalation Solution in idiopathic pulmonary fibrosis ( IPF ) preserved lung function...

UTHR : 542.66 (-0.13%)
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

The long-term, pivotal, phase 3 ADVANCE OUTCOMES study met its primary endpoint, with ralinepag achieving a statistically significant 55% reduction in risk of clinical worsening...

UTHR : 542.66 (-0.13%)
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

First-ever human clinical trial of a xenoheart intended to support potential registration through the submission of a Biologics License Application to the U.S. FDA

UTHR : 542.66 (-0.13%)
5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call

5 Insightful Analyst Questions From United Therapeutics’s Q1 Earnings Call

UTHR : 542.66 (-0.13%)
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on...

UTHR : 542.66 (-0.13%)

Barchart Exclusives

DKNG Stock Alert: What to Know as DraftKings Launches Predictions Market
DraftKings stock rallies on the launch of the prediction markets exchange. Here’s what DKeX launch really means for DKNG shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.